OQROGet OQRO Pro
Insider trade

PTC Therapeutics, Inc. (PTCT)CHIEF BUSINESS OFFICER sold ~$211K

Eric Pauwels, CHIEF BUSINESS OFFICER at PTC Therapeutics, Inc., sold ~$211K of PTC Therapeutics, Inc. shares.

~$211K
Approx. value · 3,713 sh @ $56.92
73K
Holds after · shares reported
Traded
Sep 8, 2025
Filed
Sep 9, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 15, 2025InsiderCFO sold ~$124K of PTCT shares in the open market
  2. Aug 5, 2025InsiderCEO sold ~$556K of PTCT shares in the open market
  3. Aug 15, 2025InsiderOfficer sold ~$137K of PTCT shares in the open market
  4. Aug 28, 2025InsiderDirector sold ~$84K of PTCT shares in the open market
  5. Sep 8, 2025 · this disclosureInsiderOfficer sold ~$211K of PTCT shares in the open market

What came next

  1. Sep 8, 2025Insider · 1 personInsiders: 6 sales (~$2.1M)
  2. Sep 9, 2025InsiderDirector sold ~$700K of PTCT shares in the open market
  3. Sep 11, 2025Insider · 2 peopleInsiders: 7 sales (~$2.3M)
  4. Sep 12, 2025Insider · 1 personInsiders: 4 sales (~$1.5M)
  5. Nov 4, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  6. Dec 29, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for PTC Therapeutics, Inc.

For PTC Therapeutics, Inc., OQRO holds 9 insider filings (SEC Form 4 or Form 144) and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PTCT page.

Other recent filings by Eric Pauwels, CHIEF BUSINESS OFFICER

The full history of Eric Pauwels, CHIEF BUSINESS OFFICER is on the profile page.

How this filing works

Other disclosures at PTC Therapeutics, Inc.

Everything OQRO holds on this company is on its PTCT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data